CCL11 and age-related macular degeneration: Therefore, we studied the expression of CCR3 on CD9+ granulocytes and CD4+ T-cells in peripheral blood of patients with different clinical stages of AMD, and measured the plasma levels of the CCR3 ligand CCL11.